APA

Cox M. C., Pelliccia S., Marcheselli L., Battistini R., Arcari A., Borza P. A., Patti C., Casaroli I., di Landro F., Di Napoli A., Fabbri F., Caridi M., Tafuri A., Bocci G. & Musuraca G. (20200220). The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma. : Investigational new drugs.

Chicago

Cox M Christina, Pelliccia Sabrina, Marcheselli Luigi, Battistini Roberta, Arcari Annalisa, Borza Paola Anticoli, Patti Caterina, Casaroli Ivana, di Landro Francesca, Di Napoli Arianna, Fabbri Francesca, Caridi Matteo, Tafuri Agostino, Bocci Guido and Musuraca Gerardo. 20200220. The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma. : Investigational new drugs.

Harvard

Cox M. C., Pelliccia S., Marcheselli L., Battistini R., Arcari A., Borza P. A., Patti C., Casaroli I., di Landro F., Di Napoli A., Fabbri F., Caridi M., Tafuri A., Bocci G. and Musuraca G. (20200220). The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma. : Investigational new drugs.

MLA

Cox M Christina, Pelliccia Sabrina, Marcheselli Luigi, Battistini Roberta, Arcari Annalisa, Borza Paola Anticoli, Patti Caterina, Casaroli Ivana, di Landro Francesca, Di Napoli Arianna, Fabbri Francesca, Caridi Matteo, Tafuri Agostino, Bocci Guido and Musuraca Gerardo. The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma. : Investigational new drugs. 20200220.